Rocket One Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Rocket One Inc. (RKTO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 22.33 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-30
- Rocket One Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 23.99M shares, a 78.44% increase year-over-year.
- Rocket One Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 23.89M shares, a 77.80% increase year-over-year.
- Rocket One Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 23.69M shares, a 92.57% increase year-over-year.
- Rocket One Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 17.68M shares, a 72.44% increase year-over-year.
- Rocket One Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 22.33M shares, a 80.62% increase from fiscal 2020.
- Rocket One Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 12.36M shares, a 34.90% increase from fiscal 2019.
- Rocket One Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 9.16M shares, a 82.16% increase from fiscal 2018.
- Rocket One Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 5.03M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 8 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | 23.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 23.94M shares derived: average of 2 quarters · filed 2022-03-30 | 23.86M shares derived: average of 3 quarters · filed 2022-03-30 | 22.33M shares 10-K · filed 2022-03-30 | |
| 2021-09-30 | 23.89M shares 10-Q · filed 2021-11-10 | 23.79M shares derived: average of 2 quarters · filed 2021-11-10 | 21.78M shares 10-Q · filed 2021-11-10 | 19.68M shares derived: average of 4 quarters · filed 2022-03-30 | |
| 2021-06-30 | 23.69M shares 10-Q · filed 2021-08-11 | 20.70M shares 10-Q · filed 2021-08-11 | 18.27M shares derived: average of 3 quarters · filed 2022-03-30 | 17.06M shares derived: average of 4 quarters · filed 2022-03-30 | |
| 2021-03-31 | 17.68M shares 10-Q · filed 2021-05-13 | 15.56M shares derived: average of 2 quarters · filed 2022-03-30 | 14.85M shares derived: average of 3 quarters · filed 2022-03-30 | 14.22M shares derived: average of 4 quarters · filed 2022-03-30 | |
| 2020-12-31 | 13.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 13.44M shares derived: average of 2 quarters · filed 2022-03-30 | 13.06M shares derived: average of 3 quarters · filed 2022-03-30 | 12.36M shares 10-K · filed 2022-03-30 | |
| 2020-09-30 | 13.43M shares 10-Q · filed 2021-11-10 | 12.87M shares derived: average of 2 quarters · filed 2021-11-10 | 12.00M shares 10-Q · filed 2021-11-10 | 11.53M shares derived: average of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | 12.30M shares 10-Q · filed 2021-08-11 | 11.28M shares 10-Q · filed 2021-08-11 | 10.89M shares derived: average of 3 quarters · filed 2021-08-11 | 10.64M shares derived: average of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | 10.25M shares 10-Q · filed 2021-05-13 | 10.19M shares derived: average of 2 quarters · filed 2021-05-13 | 10.09M shares derived: average of 3 quarters · filed 2021-05-13 | 9.97M shares derived: average of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | 10.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 10.01M shares derived: average of 2 quarters · filed 2021-03-16 | 9.87M shares derived: average of 3 quarters · filed 2021-03-16 | 9.16M shares 10-K · filed 2021-03-16 | |
| 2019-09-30 | 9.89M shares 10-Q · filed 2020-11-10 | 9.74M shares derived: average of 2 quarters · filed 2020-11-10 | 8.84M shares 10-Q · filed 2020-11-10 | 7.89M shares derived: average of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | 9.60M shares 10-Q · filed 2020-08-13 | 8.31M shares 10-Q · filed 2020-08-13 | 7.23M shares derived: average of 3 quarters · filed 2020-08-13 | 6.69M shares derived: average of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | 7.01M shares 10-Q · filed 2020-05-13 | 6.04M shares derived: average of 2 quarters · filed 2020-05-13 | 5.72M shares derived: average of 3 quarters · filed 2020-05-13 | 5.55M shares derived: average of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | 5.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 5.08M shares derived: average of 2 quarters · filed 2020-03-02 | 5.06M shares derived: average of 3 quarters · filed 2020-03-02 | 5.03M shares 10-K · filed 2020-03-02 | |
| 2018-09-30 | 5.08M shares 10-Q · filed 2019-11-12 | 5.06M shares derived: average of 2 quarters · filed 2019-11-12 | 5.02M shares 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | 5.04M shares 10-Q · filed 2019-08-14 | 4.99M shares 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | 4.93M shares 10-Q · filed 2019-05-15 | ||||
| 2017-12-31 | 4.27M shares 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |